MAGNESIUM SHOT BEFORE PRETERM BIRTH MAY PREVENT CEREBRAL PALSY

NCT ID NCT07524972

Recruiting now Prevention Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving magnesium sulphate to pregnant women at high risk of preterm birth can protect their babies from cerebral palsy. About 138 women between 32 and 35 weeks of pregnancy will receive either magnesium or a placebo before delivery. Researchers will then track the babies' brain development to see if the treatment reduces the risk of death or cerebral palsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: magnesium sulphate
What this could lead to: If it works, this could offer a simple, low-cost way to prevent cerebral palsy in babies born early.
What could go wrong: This is a single-center trial with 138 participants, so results may not apply broadly. Magnesium sulphate can cause side effects like flushing or low blood pressure in mothers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth cerebral palsy prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL PALSY MAGNESIUM SULFATE OVERDOSE

Contacts and locations

Locations

Suez Canal University
RECRUITING

Ismailia, Ismailia Governorate, 8366004, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.